| Pharmaceutical active ingredients: |
| Erythromycin |
| Available forms, composition and doses of Eryc: |
| Capsules, Delayed Release; Oral; Erythromycin 125 mgCapsules, Delayed Release; Oral; Erythromycin 250 mgCapsules, Delayed Release; Oral; Erythromycin 333 mg |
| Eryc medical category: |
| Human:Acne treatment preparationsAntibacterialsErythromycinsEye anti-infectives and antisepticsMacrolidesTopical antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01FA01 - ErythromycinS01AA17 - Erythromycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerFauldingHospiraMayne PharmaTaro Pharmaceutical IndustriesTevaWarner Chilcott |
| Related documents and information about Eryc: |
| Eryc prescribing information (PDF) |